AV Nelfinavir
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{up|PHA antivirals by mechanism}} {{tp|p=33333424|t=2021. Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking molecular dynami…“) |
K |
||
| Zeile 1: | Zeile 1: | ||
{{up|PHA antivirals by mechanism}} | {{up|PHA antivirals by mechanism}} | ||
| + | {{tp|p=32374457|t=2020. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections |pdf=|usr=}} | ||
{{tp|p=33333424|t=2021. Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking molecular dynamics simulation and MM/GBSA study.|pdf=|usr=023}} | {{tp|p=33333424|t=2021. Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking molecular dynamics simulation and MM/GBSA study.|pdf=|usr=023}} | ||
Aktuelle Version vom 11. April 2021, 09:16 Uhr
| PHA antivirals by mechanism |
32374457 2020. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections
33333424 2021. Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking molecular dynamics simulation and MM/GBSA study.
